Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies. The pattern of inattention, ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies.

Stimulant medications and non-stimulant medications affect brain chemistry through different mechanisms”— Dr. Stanford ...

NEW YORK, July 12, 2024 /PRNewswire/ -- The global central nervous system (CNS) stimulant drugs market size is estimated to grow by USD 6.48 billion from 2023-2027, according to Technavio. The market ...

A research team of the Center for Brain Research at the Medical University of Vienna has identified a specific cell group in the brain responsible for shifts in the sleep-wake rhythm caused by ...

Understood reports ADHD meds may raise heart risks; lifestyle factors like sleep issues and weight gain also affect heart health in those with ADHD.

Lisdexamfetamine dimesylate 30 mg, 50 mg, 70 mg; caps. After oral administration, lisdexamfetamine is rapidly absorbed from the GI tract and is converted to the active drug dextroamphetamine.

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

Long-term use of stimulant medication for attention-deficit/hyperactivity disorder (ADHD) does not appear to cause lasting changes in brain development, according to a study published in Progress in ...